South Korea's Kospi index dropped more than 8% on Friday, reflecting global tech sector instability and concerns about stricter AI regulations under Democratic governments. This sharp decline signals heightened market volatility and investor caution, making South Korean stocks a key focus for Sunday night trading. Investors will be watching closely for any further developments or policy announcements that could impact the market's direction.
South Korean stocks are a Sunday night focus as of Nov 09, 2026 02:31 WIB. For readers following the Technology sector on Pluang, today 80 of 150 priced US tech stocks rose while 68 fell. Notable movers include FIVN (Five9 Inc) down 17.63%, TEAM (Atlassian Corporation PLC) down 16.15%, and ATOM (Atomera Incorporated) up 15.55%.
NVIDIA's Board of Directors has started an independent investigation after reports that CEO Jensen Huang was targeted by a foreign intelligence operation. The inquiry, led by independent directors and external counsel, aims to ensure no national secu...
Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...
AVITA Medical announced an investor webinar on November 11, 2026, where CEO Cary Vance and CFO David O’Toole will discuss the company's third-quarter 2026 financial and business results. The session will include a Q&A segment for participants who can...
CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...
Investing $1,000 in Procter & Gamble (P&G) in 2006 and reinvesting all dividends grew the investment to $4,656 by 2026. P&G's steady demand for everyday products supports 70 consecutive years of dividend increases, with dividends rising from $0.31 to...
